Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-06-24
The filing discloses a material acquisition transaction: Jet.AI Inc. entered into an Amended and Restated Agreement and Plan of Merger and Reorganization with flyExclusive, Inc., whereby Jet.AI will distribute SpinCo shares to stockholders and SpinCo will merge with flyExclusive's subsidiary. The filing reports on the stockholder vote status for this merger, with 688,430 shares (48.4% of outstanding) represented at the June 23 reconvened special meeting, approximately 99% voting in favor, but the meeting adjourned again to July 2, 2026 pending final approval. This is a change-of-control transaction requiring stockholder approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-24
The filing discloses post-acquisition integration progress following NextBoat's acquisition of Apex Marine Companies, completed on May 1, 2026. While the 8-K itself is filed under Item 7.01 (Regulation FD Disclosure) rather than a dedicated M&A item, the press release centers on material developments stemming from the acquisition: inventory integration, sales performance (15 vessels sold), service expansion, facility consolidation, and $90,000 in monthly cost savings. The acquisition itself is a material event that would affect a reasonable investor's assessment of the company's operations and financial position.
View raw filing on EDGAR →
6-K
M&A activity
confidence 99%
filed 2026-06-24
GSK announces commencement of a tender offer to acquire all outstanding shares of Nuvalent, Inc. for $124.00 per share pursuant to an Agreement and Plan of Merger dated June 9, 2026. This is a material acquisition transaction involving a direct wholly-owned subsidiary of GSK acquiring a NASDAQ-listed biopharmaceutical company, with the Nuvalent Board recommending stockholder acceptance of the offer.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 8.01
The disclosure announces expiration of the Hart-Scott-Rodino waiting period for a previously-disclosed merger agreement between Cross Country Healthcare and KL Criss Cross Intermediate, LLC, satisfying a major closing condition. The filing also references a concurrent sale of the Company's locums business division to an affiliate of the acquirer. This constitutes material M&A activity—a change of control transaction with expected closing in Q3 2026 and a shareholder vote scheduled for July 16, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-23
Item 7.01
The filing discloses a proposed acquisition of Vacuumschmelze GmbH & Co. KG and related group companies from Ara Partners, with an investor presentation furnished as Exhibit 99.1. This constitutes material M&A activity under Item 7.01 (Regulation FD Disclosure), which is commonly used to furnish investor materials related to significant transactions. The acquisition of a named foreign entity represents a material acquisition event that would affect investor assessment of the registrant.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 8.01
FirstCash announced a recommended cash acquisition of Ramsdens Holdings PLC for approximately £206 million ($273 million USD) through its subsidiary Chess Bidco Limited, expanding FirstCash's U.K. pawn store presence from approximately 296 to over 470 combined locations. The transaction is subject to shareholder and regulatory approvals with expected completion by end of 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-06-23
Item 1.01
Nuvectis entered into a material definitive license agreement with Haisco Pharmaceutical Group on June 22, 2026, acquiring exclusive ex-China rights to develop, manufacture, and commercialize two clinical-stage drug candidates (NXP100 and NXP200). The transaction involves an upfront payment of $20 million, up to $20 million in initial development milestones, and up to $1.4 billion in contingent payments, representing a material acquisition of intellectual property and development rights that transforms the company's pipeline and strategy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 7.01
Sunstone Hotel Investors has entered into a definitive agreement to sell the 821-room Hyatt Regency San Francisco to Blackstone Real Estate for $279 million. This is a material disposition of a significant asset representing a substantial portion of the company's real estate portfolio. The transaction is expected to close in late July or early August 2026, and the company has already begun deploying proceeds into share repurchases, demonstrating the materiality of this capital event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-23
Item 5.01
The company's emergence from bankruptcy resulted in a material change of control, with certain holders of Old September 2029 Senior Secured Notes and DIP Claims acquiring approximately 67% of the Reorganized Common Equity through debt-to-equity conversion. This change of control was effectuated through the bankruptcy reorganization plan and represents a fundamental shift in ownership and control of the registrant.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-23
Item 8.01
RMR LLC, the Company's majority-owned subsidiary, entered into amended management agreements with OPI upon OPI's emergence from Chapter 11 bankruptcy on June 17, 2026. The disclosure centers on the restructuring and renewal of material contractual relationships following OPI's reorganization, including new fee structures ($14.0 million annual business management fee, 3% property management fee, 5% construction supervision fee) and equity issuances (2% immediate, up to 8% contingent on performance metrics). While technically a contract renewal rather than a traditional M&A transaction, this represents a material restructuring of RMR's relationship with a significant client emerging from bankruptcy protection, affecting the Company's future cash flows and equity interests.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 1.01
Kimbell Royalty Partners closed a $145.9 million acquisition of mineral and royalty interests from Mesa Royalties on June 22, 2026, comprised of $44.0 million in cash and approximately 6.9 million newly issued common units, adding approximately 1,390 Boe/d of production across 16 Permian counties.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-23
EX-99.3
Orla Mining Ltd. has entered into a court-approved plan of arrangement under the Canada Business Corporations Act whereby Equinox Gold Corp. will acquire all issued and outstanding shares of Orla Mining Ltd. in exchange for Equinox common shares (1.00 per Orla share) and US$0.0001 cash per share. The arrangement requires shareholder approval by at least 66⅔% vote at a special meeting scheduled for July 22, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-23
Item 8.01
The filing discloses the adjournment of a special stockholder meeting to vote on TWO's proposed acquisition by CrossCountry Intermediate Holdco, LLC (an affiliate of CrossCountry Mortgage, LLC). The transaction involves a $12.00 per share cash offer representing a 21% premium to unaffected share price and is described as "fully financed" with 47 of 53 regulatory approvals secured and expected to close in August 2026. This is a material acquisition event requiring stockholder approval, making it an ma_activity disclosure.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-06-23
EX-99.1
ASUR's Board proposes to internalize technical assistance and technology transfer services currently outsourced to ITA through a merger of one or more entities into ASUR, subject to shareholder approval. This represents a material acquisition or change in business structure. The transaction is expected to result in issuance of approximately 7.25 million new shares and is accompanied by extraordinary dividends of Ps. 10.00 per share, indicating a significant capital event. While the language frames this as "internalization" rather than a traditional M&A transaction, the substance—bringing an outsourced business function in-house through merger and equity issuance—constitutes material acquisition activity requiring shareholder approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 8.01
The filing discloses the completion of all regulatory approvals for a material merger transaction. ProAssurance entered into a Merger Agreement on March 19, 2025, with The Doctors Company, whereby ProAssurance will become a wholly owned subsidiary. The disclosure confirms that as of June 23, 2026, all required regulatory approvals—including stockholder approval (June 24, 2025), FTC early termination (July 2, 2025), and all insurance regulator approvals—have been received, with closing expected on June 26, 2026. This represents a change of control and material acquisition activity requiring 8-K disclosure under Item 1.01 or 2.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-23
EX-99.1
This press release announces the filing and mailing of meeting materials for a special shareholder meeting to approve a business combination (plan of arrangement) between Equinox Gold and Orla Mining. The transaction involves Equinox Gold acquiring all outstanding common shares of Orla Mining, with each Orla share exchanged for 1.00 Equinox Gold common share and US$0.0001 in cash, resulting in a combined company where existing Equinox Gold and former Orla shareholders will own approximately 67% and 33%, respectively. This is a material acquisition and change of control event requiring shareholder approval.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 1.01
Boundless Bio entered into a definitive merger agreement with Serapha Bio, whereby Serapha will be the surviving entity and Boundless stockholders will own approximately 3.7% of the combined company post-closing. The transaction includes a concurrent $230 million private placement financing and is expected to close in Q4 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-23
Item 1.01
In connection with its Chapter 11 bankruptcy proceedings, Sangamo entered into stalking horse asset purchase agreements, a mechanism used in bankruptcy proceedings to facilitate asset sales and disposition activities.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 8.01
The filing discloses that the HSR Act waiting period for a previously announced merger between TruBridge and Inventurus Knowledge Solutions expired on June 22, 2026, removing a key closing condition. The merger involves Merger Sub merging with TruBridge, with TruBridge becoming a wholly owned subsidiary of Parent—a material change of control transaction. This is a significant milestone in the completion of a material acquisition/merger.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 7.01
The disclosure concerns a revised, unsolicited tender offer from Zodiac Partners II to acquire all outstanding shares of DXL at $0.84 per share. The Board is actively evaluating this offer and will make a recommendation to stockholders. This constitutes a material acquisition activity (potential change of control) that would significantly affect investor assessment of the company's future, even though the offer remains unsolicited and under review.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 8.01
This Item 8.01 discloses a material acquisition event: Catalyst Pharmaceuticals entered into a Merger Agreement with Angelini Pharma on May 6, 2026, providing for the merger of Angelini's subsidiary with Catalyst, with Catalyst surviving as a wholly-owned subsidiary of Angelini Pharma. The filing updates that the FTC granted early termination of the HSR Act waiting period on June 16, 2026, and the parties expect closing in Q3 2026 subject to customary conditions including stockholder approval. This is a change-of-control transaction material to any reasonable investor.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-23
EX-99.1
Equinox Gold Corp. proposed to acquire all outstanding common shares of Orla Mining Ltd. by way of a court-approved plan of arrangement, with an exchange ratio of 1.00 Equinox Gold share plus $0.0001 cash per Orla share, involving the issuance of up to 421.8 million Equinox Gold shares. The transaction, described as transformative, requires shareholder approval at a special meeting scheduled for July 22, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 1.01
This disclosure reports Amendment No. 1 to a business combination agreement (BCA) between Eureka Acquisition Corp (SPAC), Marine Thinking Inc., and an amalgamation subsidiary, dated June 12, 2026. The amendment modifies post-closing director requirements under section 5.19 of the original BCA filed October 29, 2025. Material amendments to definitive M&A agreements constitute ma_activity under Item 1.01, as they affect the terms and conditions of the pending business combination.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-06-23
Item 1.01
HeartSciences entered into a definitive Agreement and Plan of Merger with Fortitude Mining Holdings, Inc. on June 23, 2026, whereby Fortitude will merge with HeartSciences' subsidiary in an all-stock transaction expected to close in H2 2026. The transaction represents a material change of control, with Fortitude's parent DCG expected to own approximately 95% of the combined company post-closing and HeartSciences shareholders retaining approximately 5%, fundamentally transforming HeartSciences' business and ownership structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 2.01
Quantum Computing Inc. completed the acquisition of NHanced Semiconductors, Inc. for $73.1 million in upfront consideration (cash and stock) plus up to $72.0 million in earnout payments. The acquisition adds semiconductor and nanophotonics fabrication capabilities and launches Fab 2 to accelerate the company's path to commercial-scale production.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 1.01
Silicon Valley Acquisition Corp. (SVAQ) entered into a Business Combination Agreement with EigenQ, Inc. on June 17, 2026, pursuant to which SVAQ's merger subsidiary will merge with EigenQ, with EigenQ continuing as the surviving company and becoming a wholly-owned subsidiary of SVAQ. This is a material acquisition/change of control transaction with a $2.93 billion valuation, requiring shareholder approval and resulting in a combined company listing on a national securities exchange. The filing explicitly discloses this under Item 1.01 (Entry into a Material Definitive Agreement) and describes the merger structure, consideration, and post-closing governance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-23
Item 7.01
HeartSciences entered into a definitive Agreement and Plan of Merger with Fortitude Mining Holdings on June 23, 2026, combining the two companies in an all-stock transaction. The merger agreement is a material acquisition/change of control event, with the combined company expected to operate under the Fortitude brand and trade on Nasdaq. This is disclosed in Item 7.01 (Regulation FD Disclosure) and is supported by the conference call transcript and social media posts furnished as exhibits, which detail the transaction structure, financial profile, and strategic rationale.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-23
Item 2.01
The filing discloses the completed sale of the Hilton Garden Inn Austin Downtown hotel property by Ashford Hospitality Trust's subsidiary for $26.85 million in cash on June 18, 2026, pursuant to an Agreement of Purchase and Sale dated April 30, 2026. This is a material disposition of a hotel asset that would affect a reasonable investor's assessment of the company's portfolio and financial position. The supplemental pro forma statements demonstrate the significance of the transaction, showing removal of $23.8 million in net hotel property value and $25.7 million in associated mortgage debt.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-06-23
EX-99.1
This is a definitive announcement of a material acquisition: Ballard Power Systems has entered into a definitive agreement to acquire UK-based GeoPura Limited for total upfront consideration of £275.0 million (~US$400 million enterprise value), funded through £82.5 million in cash and ~50.8 million newly issued Ballard shares. The transaction is transformative, establishing Ballard as a vertically integrated hydrogen ecosystem provider, and includes contingent consideration of up to £27.5 million. The acquisition is expected to close in H2 2026 and has been unanimously approved by both boards.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-23
EX-99.1
This news release announces the filing of meeting materials and receipt of an interim court order for Orla Mining's special shareholder meeting to approve a material acquisition—specifically, a court-approved plan of arrangement whereby Equinox Gold Corp. will acquire all outstanding common shares of Orla. The arrangement agreement was dated May 12, 2026, and shareholders will vote on July 22, 2026. The Board unanimously recommends approval, and insiders holding 26.4% of shares have committed to vote in favor. This is a transformative M&A event creating a combined North American senior gold producer.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-23
The filing discloses entry into a definitive Agreement and Plan of Merger (Item 1.01) whereby Black Pearl Equities will acquire all outstanding shares of Selectis Health for $5.75 per share in cash through a tender offer followed by a short-form merger. This is a material acquisition transaction with clear economic terms, board approval, and no financing contingencies, representing a change of control of the company.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-23
Item 8.01
The Company engaged CBRE's National Retail Partners on June 19, 2026 to "list and market for sale thirty-five of those fifty-nine properties as a portfolio sale transaction." This represents a material disposition of approximately 59% of the Company's real estate portfolio. Although the transaction is contemplated rather than completed, the engagement of a major broker to market a substantial portfolio for sale constitutes a material M&A/disposition activity that would affect a reasonable investor's assessment of the registrant's strategic direction and asset base.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-23
Item 1.01
Backblaze entered into a Master Strategic Agreement with CoreWeave effective June 16, 2026, representing a material multi-year commercial arrangement valued at approximately $335 million over five to seven years. The agreement establishes a significant strategic partnership for HDD-based storage capacity supporting CoreWeave's AI infrastructure and includes equity consideration through warrant issuance of 4.2 million shares.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-23
EX-99.1
Vox Royalty completed the sale of the Federation Gold Royalty for A$8,000,000 in cash, representing a disposition of a material asset. The press release explicitly states "Vox Royalty sells Federation Gold Royalty" and describes the transaction as a completed divestment. While the company characterizes it as "opportunistic," the sale of a royalty interest constitutes a material disposition event requiring disclosure under M&A activity categories.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-06-23
EX-99.1
LEIFRAS announced entry into a stock transfer agreement to acquire 100% of Swift Japan Co., Ltd. for approximately JPY 454.6 million, with closing expected July 1, 2026. This is a material acquisition that expands the company into the childcare sector and represents a strategic business combination. The press release explicitly describes it as an acquisition and partnership that will extend customer reach and create synergies with the company's existing sports education business.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-22
Item 2.01
Kosmos Energy completed the sale of its 40.375% participating interest in the Ceiba Field and Okume Complex production assets in Block G offshore Equatorial Guinea to Panoro Energy ASA on June 16, 2026. The company received approximately $127 million in upfront cash consideration plus up to $39.5 million in contingent consideration. This is a material disposition of significant oil and gas assets that materially affects the company's asset base and future cash flows, triggering Item 2.01 disclosure requirements.
View raw filing on EDGAR →
6-K
M&A activity
confidence 85%
filed 2026-06-22
EX-99.1
The exhibit discloses a material change involving a "further strengthening of its strategic partnership with Mitsubishi Materials" through an amended and restated investor rights agreement. Mitsubishi Materials will acquire 1.2 million common shares through open market purchases, extending the agreement until November 30, 2028, and returning Mitsubishi Materials' ownership to approximately 5%. This constitutes a material change of control or significant equity transaction that would affect a reasonable investor's assessment of the registrant's capital structure and strategic positioning.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-22
EX-99.1
This exhibit announces the closing of Sierra Madre's acquisition of First Majestic's Del Toro Silver Mine subsidiary for up to US$60M in cash and stock consideration. The transaction involves a share purchase agreement dated December 17, 2025, with closing announced June 22, 2026, including immediate payments of US$20M cash plus 10.87M shares, plus contingent milestone payments up to US$20M more. This is a material acquisition completion that would significantly affect investor assessment of both parties' asset portfolios and financial positions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-22
Item 7.01
HIVE announced two material transactions: (1) a USD $220 million three-year sovereign AI GPU contract with Bell AI Fabric for Cohere Inc. involving deployment of NVIDIA Grace Blackwell infrastructure in Merritt, BC, and (2) the acquisition of the Big Boden 32 MW data center facility in Boden, Sweden from Bodens Utvecklings AB.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-06-22
EX-99.1
MDA Space has signed a definitive agreement to acquire 100% of Blue Canyon Technologies LLC for US$620 million (approximately C$874 million) in an all-cash transaction. The press release explicitly states this is a material acquisition that expands MDA's total addressable market, adds a profitable cash-generating business with 18-year history, and is expected to be accretive to Adjusted EBITDA and Adjusted EPS in 2027. The transaction is expected to close by end of 2026 subject to customary closing conditions and regulatory approvals.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-22
Item 7.01
This Item 7.01 disclosure updates the status of the previously announced merger between Paramount Skydance Corporation and Warner Bros. Discovery, Inc., specifically announcing that the Canadian Competition Act waiting period expired on June 20, 2026, and that the South African Competition Commission approved the Merger on June 19, 2026. These are material regulatory clearances advancing a transformative M&A transaction toward closing, making this an ma_activity event.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-22
Item 7.01
AbbVie announced a definitive agreement to acquire Apogee Therapeutics for $135.11 per share in cash, valuing the target at approximately $10.9 billion. The press release explicitly states "AbbVie will acquire all outstanding shares of Apogee" and describes this as a material acquisition that "complements AbbVie's existing immunology portfolio." This is a clear material acquisition event requiring disclosure under Item 1.01 or 2.01, disclosed here via Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-06-22
Item 7.01
Booz Allen announced entry into a definitive agreement to acquire Ultra I&C Mission Solutions business for $720 million, a material acquisition of a defense technology business. The press release explicitly states the company "has entered into a definitive agreement" and describes the strategic rationale, expected financial performance (double-digit revenue growth, EBITDA margins above 20%), and expected closing timeline (Q2 FY2027). This is a classic Item 1.01 material acquisition disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-22
Item 1.01
The filing discloses entry into a new investment advisory agreement on June 22, 2026, which became effective upon the closing of an acquisition of Stellus Capital Management, LLC by Ridgepost Capital, LLC—a change of control event. While the agreement terms are identical to the prior agreement, the triggering event is a material acquisition that resulted in a change in control of the Advisor, making this a material M&A activity disclosure under Item 1.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-22
EX-99.1
This exhibit discloses ZTO Express's acquisition of the remaining 36.20% shareholding in TuXi Tech (567.5 million shares) for approximately RMB1,305.3 million through Share Purchase Agreements dated June 22, 2026. Upon completion, TuXi Tech will become a wholly-owned subsidiary. This is a material acquisition that will consolidate the company's ownership of a last-mile delivery platform and is explicitly identified as a connected transaction under Hong Kong Listing Rules Chapter 14A.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-22
Item 1.01
Apogee entered into a definitive Agreement and Plan of Merger with AbbVie on June 18, 2026, under which AbbVie will acquire all outstanding shares of Apogee for $135.11 per share in cash, valuing the company at approximately $10.9 billion. The transaction constitutes a change of control with Apogee surviving as a wholly owned subsidiary, subject to customary closing conditions including shareholder approval and regulatory clearances, with expected closing in Q3 2026.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-06-22
EX-99.1
Castor Maritime announces entry into an agreement to acquire a 2023-built Kamsarmax bulk carrier vessel for $37.5 million through a wholly-owned subsidiary. The acquisition is a material capital deployment that will expand the company's fleet from 9 to 10 vessels and represents a significant asset purchase in the shipping business. The disclosure explicitly states the acquisition is expected to close by end of quarter, subject to customary closing conditions.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-22
Item 8.01
The filing discloses the consummation of a merger combination between the registrant and RTB Digital, Inc. on May 12, 2026, with completion of share issuance obligations under the merger agreement as of the filing date. This represents a material acquisition/change of control event, even though disclosed under Item 8.01 rather than the typical Item 1.01 or 2.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-22
Item 8.01
Baker Hughes discloses an update on its pending acquisition of Chart Industries, specifically that the parties are in discussions with the European Commission regarding regulatory commitments to obtain Phase I clearance. The filing confirms the Merger Agreement entered into on July 28, 2025, and provides a status update on the regulatory approval process with an expected closing in July 2026. This is a material acquisition activity disclosure under Item 8.01 (Other Events), as it concerns the progress and regulatory status of a significant M&A transaction.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-06-22
EX-99.1
PLDT announced that VITRO Inc. (a wholly-owned subsidiary of ePLDT, itself a wholly-owned subsidiary of PLDT) has submitted a registration statement for a proposed REIT IPO. The disclosure describes a planned secondary offering of up to 1.9 billion shares expected to raise gross proceeds of up to ₱24.2 billion, representing approximately 48.95% of VITRO REIT's post-offering capital. This constitutes a material capital-raising and restructuring activity involving the creation of a new publicly-traded entity within the PLDT Group's digital infrastructure portfolio, which would materially affect investor assessment of PLDT's capital structure and strategic positioning.
View raw filing on EDGAR →